Evaluation of pharmaceutical industry-led access programmes: a standardised framework
- PMID: 31423348
- PMCID: PMC6688691
- DOI: 10.1136/bmjgh-2019-001659
Evaluation of pharmaceutical industry-led access programmes: a standardised framework
Abstract
Pharmaceutical industry-led access programmes are increasing in number and scope worldwide. We present a new standardised framework for evaluation of these programmes that includes three components: a taxonomy of 11 access programme strategies; a series of logic models, one for each strategy and a set of measurement indicators. The logic models describe pathways of potential programme impact. Concepts relevant across a broad range of strategies were prioritised for inclusion in logic models to ensure consistency and to facilitate synthesis and learning across programmes. Each concept has at least one corresponding measurement indicator with metadata that includes the definition, details on how it should be measured and recommended data sources. The framework establishes a shared language for the collection and reporting of meaningful industry-led access programme information. Broad adoption by programme developers and implementing partners in the for-profit sector and beyond could facilitate shared learning on effective strategies and best practices.
Keywords: health systems evaluation; public health.
Conflict of interest statement
Competing interests: All authors report grants from Access Accelerated, during the conduct of the submitted work. PCR reports grants from Sandoz International GmBH and Gilead Sciences, outside the submitted work. ROL reports non-financial support from Novartis International AG and grants from Sandoz International GmBH and Gilead Sciences, outside the submitted work. NS reports a grant from MSD for Mothers, outside the submitted work. PA report a grant from Sandoz International GmBH, outside the submitted work. EHL reports personal fees from Vertex Pharmaceuticals, outside the submitted work. VJW reports grants from Sandoz International GmBH and Gilead Sciences, outside the submitted work.
References
-
- Merck MSD. Mectizan donation program. Available: http://www.mectizan.org [Accessed 14 Nov 2018].
-
- Novartis Sms for life. Available: https://www.novartis.com/about-us/corporate-responsibility/expanding-acc... [Accessed 14 Nov 2018].
Publication types
LinkOut - more resources
Full Text Sources